Agent having a destructive effect on malignant tumors and method for the production thereof

Details for Australian Patent Application No. 2003285351 (hide)

Owner C.Y.L. Pharmazeutika GmbH

Inventors Herwig, Ralf; Ferdinand, Peter; Groke, Karl

Agent Griffith Hack

Pub. Number AU-B-2003285351

PCT Number PCT/EP2003/0507

PCT Pub. Number WO2004/047832

Priority A1778/2002 27.11.02 AT

Filing date 13 October 2003

Wipo publication date 18 June 2004

Acceptance publication date 1 July 2010

International Classifications

A61K 31/194 (2006.01)

A61K 31/05 (2006.01)

A61K 31/198 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): A1778/2002 27.11.02 AT

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003285351

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name C.Y.L. HANDELSGES.M.B.H., Application No. 2003285351, under INID (71) correct the name to read C.Y.L. Pharmazeutika GmbH.

1 July 2010 Application Accepted

  Published as AU-B-2003285351

2 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003285352-COMMUNICATION DEVICE AND COMMUNICATION SYSTEM

2003285350-DIFFERENTIAL PROTECTION FOR SYNCHRONOUS MACHINES